Conditions: Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 994
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to learn if initiating treatment with BMS-51248 (Dapagliflozin) in combination with metformin XR can improve diabetes control in patients with Type 2 Diabetes who do not receive any pharmacological treatment for diabetes, when compared to initial treatment with monotherapy dapagliflozin or metformin XR. The safety of this treatment will also be studied

Detailed description:

Arms:
arm 1: Dapagliflozin (5 mg) + Metformin XR (up to 2000 mg) arm 2: Dapagliflozin (5 mg) arm 3: Metformin XR (500 mg up to 2000 mg)

Interventions: intervention 1: Dapagliflozin intervention 2: Metformin XR
Intervention descriptions: intervention 1: Tablets, Oral, Once daily, 24 weeks intervention 2: Tablets, Oral, Once daily, 24 weeks

Protocol document: